Español(Spanish Formal International)Português (pt-PT)Russian (CIS)Polish (Poland)English (United Kingdom)
logo-frase

ISO_9001IPAC1_70

Low-dose corticosteroids to treat septic shock: a critical literature review.

Crit Care Nurse. 2011 Dec;31(6):16-26

Authors: Yarema TC, Yost S

Abstract
Septic shock is the 13th leading cause of death in the United States. The rate of severe sepsis nearly doubled and mortality increased more than 60% during the 10-year period ending in 2003. Systemic inflammatory response syndrome has noninfectious and infectious causes. Noninfectious ones include burns, trauma, severe pancreatitis, and therapy with monoclonal antibodies or immunomodulatory drugs such as interleukin 2. Progression from sepsis syndrome to septic shock is caused by a series of immune responses. As an infectious injury progresses, host activation of the coagulation, immunological, and stress response systems ensues, resulting in tissue hypoperfusion and organ failure. Early studies with small numbers of patients suggest that treatment with low-dose corticosteroids has marked beneficial effects on shock reversal, the immune system, and the hemodynamic profile. Low-dose corticosteroids should only be administered to a subset of patients with septic shock who are unresponsive to fluid replacement and vasopressor therapy.

PMID: 22135328 [PubMed - in process]

Read more: Low-dose corticosteroids to treat septic shock a critical literature review

Ongoing Promotions

- Order your MAb in 2011 and get 10% discount

- Order 50 mg or more of your MAb and get 5% discount

- Sequence the DNA of your MAb Hybridoma and get 20% of the normal price

- Start your fusion antibody project in 2011 and get 10% discount!

Ask for Monoclonal Antibodies Quotation

Tell us more about your specific project needs, and we will be happy to send you a quotation. You can also request the visit of our Monoclonal Antobody core facility manager for a discussion of the best approach to your research. Please click here or contact us by phone to the (+351) 212956721